Marty Barrington
Analyst · Wells Fargo
Thanks, Sarah and good morning, everyone. Altria had yet another year of excellent business results and outstanding shareholder returns in 2015. We continue to deliver against our two long-term financial goals. First, Altria grew adjusted diluted earnings per share by nearly 9% in line with our long-term growth objective. Second, Altria paid nearly $4.2 billion in dividends to our shareholders, consistent with our goal of paying out approximately 80% of adjusted diluted EPS. Also during the year we raised our dividend per share by 8.7%, aligned with our goal to raise the dividend in line with adjusted diluted EPS growth. This was the 49th time we have raised the dividend in the last 46 years. We also completed our $1 billion share repurchase program and announced a new $1 billion program that we expect to complete by the end of 2016. In Altria, SABMiller’s largest shareholder supported the approximately $107 billion business combination between Anheuser-Busch InBev and SABMiller which will create the first truly global beer company. We strongly believe that the deal is in the best interest of our shareholders, offering a significant premium on our very larger beer investment and continued participation in the global beer profit pool on attractive terms. The size of the premium we capture will ultimately depend on final closing prices, exchange rates and any proration that might occur, but as an example, as of the date of the agreement in November the terms of the partial share alternative represented an approximate 43% premium to SABMiller’s share price on September 14, 2015. For 2015, Altria delivered a total shareholder return of more than 23%, significantly outperforming both the S&P 500 and the Food Beverage and Tobacco index, and as a reminder our total shareholder returned was 29% in 2013 and 35% in 2014. So let's turn to the businesses that supported those results. Our core tobacco companies delivered on their objectives by growing income and strengthening their market leadership positions. The smokeable product segment had a very strong 2015 with double-digit income growth and Marlboro's fourth consecutive year of modest retail share growth in line with its strategy. Adjusted OCI grew nearly 11%, driven primarily by higher pricing, volume growth and the benefit of the federal tobacco quota buyout expiration. Fourth quarter adjusted OCI growth was more modest due primarily to trade inventory movements and lapping the end of the quota buyout payments. The segment also expanded adjusted OCI margins in both periods with full year margins of more than 46%. Marlboro strengthened in 2015, gaining two-tenths of retail share in both the fourth quarter and the full year. In November PM USA expanded distribution of Marlboro Midnight menthol nationally, offering adult menthol smokers a bold unique menthol flavor. Voluntarily, we expect Marlboro Midnight menthol to build on the very positive momentum we've seen from the Marlboro Black Family, which now has grown for 20 consecutive quarters. Higher cigar shipment volume contributed to the smokeable segment’s performance in both periods. Middleton grew Black & Milds volume by over 5% in the quarter and nearly 4% for the year, continuing to build on the brand’s strength in a more profitable kicked segment. In our smokeless product segment, USSTC once again delivered on its strategy to increase income by growing volume and maintain modest share momentum on Copenhagen and Skoal combined. Adjusted OCI grew more than 8% in the fourth quarter and nearly 5% for the full year. For the full year higher pricing more than offset higher promotional spending and cost. Copenhagen and Skoal increased their combined retail share by three-tenths for the year. We are pleased with Copenhagen's continued strength which grew nearly a full share point in 2015. Last year Copenhagen was the fastest growing smokeless brand in the category. And to build on the strength, USSTC is planning to expand Copenhagen Mint nationally later this quarter. Copenhagen Mint will be available at a popular price and USSTC will support its expansion with a strong awareness and trial generating plan. In innovative tobacco products, Nu Mark continued building a portfolio of tobacco products using its strong internal capabilities and its partnership with Philip Morris International. In November, based on encouraging results from lead markets, Nu Mark continued its disciplined expansion of Mark 10 XL e-vapor products to additional select retail chains. With respect to heat-not-burn products, we continue to support PMI as it prepares for a 2016 product application to the FDA for a modified risk tobacco product designation and we look forward to discussing more about our plans for U.S. commercialization at the appropriate time. The wine business continued to perform well. Ste. Michelle grew OCI almost 4% in the fourth quarter and more than 13% for the year. Ste. Michelle's premium wines continued to be recognized as leaders in the industry, garnering more than 250 90 plus ratings in 2015, up nearly 40% from last year. So 2015 was an excellent year for our premium brands, our company and our shareholders. Turning to 2016 and beyond, Altria is implementing a productivity initiative designed to maintain its operating company's leadership and cost competitiveness, this initiative is expected to deliver approximately $300 million in annual productivity savings by the end of 2017, and as a result of reinvesting some of those savings strengthen our business capability. The savings will come from reduced spending on certain SG&A infrastructure and a leaner organization. Some of the productivity savings will be invested in important initiatives such as brand building, harm reduction and regulatory capabilities. Continually challenging our cost structure and investing in the future remain important for us as we focus on delivering strong results for the long-term. As to guidance, in 2016 Altria expects to deliver full year adjusted diluted EPS in the range of $3 to $3.05 representing growth of 7% to 9% from our 2015 adjusted diluted EPS base of $2.80. This guidance does not include any impact from the proposed AB InBev and SABMiller business combination as the transaction remains subject to certain approvals and the closing date has not yet been determined. And now I will turn things over to Billy for more detail on our performance.